Structure

Physi-Chem Properties

Molecular Weight:  422.17
Volume:  441.663
LogP:  5.999
LogD:  3.032
LogS:  -2.975
# Rotatable Bonds:  5
TPSA:  111.13
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  3
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.328
Synthetic Accessibility Score:  3.223
Fsp3:  0.24
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  1

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.973
MDCK Permeability:  9.546707588015124e-06
Pgp-inhibitor:  0.485
Pgp-substrate:  0.93
Human Intestinal Absorption (HIA):  0.022
20% Bioavailability (F20%):  0.996
30% Bioavailability (F30%):  0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.005
Plasma Protein Binding (PPB):  92.23246002197266%
Volume Distribution (VD):  0.911
Pgp-substrate:  8.866416931152344%

ADMET: Metabolism

CYP1A2-inhibitor:  0.776
CYP1A2-substrate:  0.176
CYP2C19-inhibitor:  0.859
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.85
CYP2C9-substrate:  0.791
CYP2D6-inhibitor:  0.857
CYP2D6-substrate:  0.236
CYP3A4-inhibitor:  0.232
CYP3A4-substrate:  0.061

ADMET: Excretion

Clearance (CL):  8.686
Half-life (T1/2):  0.761

ADMET: Toxicity

hERG Blockers:  0.023
Human Hepatotoxicity (H-HT):  0.76
Drug-inuced Liver Injury (DILI):  0.412
AMES Toxicity:  0.024
Rat Oral Acute Toxicity:  0.32
Maximum Recommended Daily Dose:  0.437
Skin Sensitization:  0.949
Carcinogencity:  0.061
Eye Corrosion:  0.003
Eye Irritation:  0.783
Respiratory Toxicity:  0.117

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC93552

Natural Product ID:  NPC93552
Common Name*:   5,7,3',4'-Tetrahydroxy-2',5'-Di(3-Methylbut-2-Enyl)Isoflavone
IUPAC Name:   3-[3,4-dihydroxy-2,5-bis(3-methylbut-2-enyl)phenyl]-5,7-dihydroxychromen-4-one
Synonyms:  
Standard InCHIKey:  RWGZXUWGOARVDQ-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C25H26O6/c1-13(2)5-7-15-9-18(17(8-6-14(3)4)25(30)23(15)28)19-12-31-21-11-16(26)10-20(27)22(21)24(19)29/h5-6,9-12,26-28,30H,7-8H2,1-4H3
SMILES:  CC(=CCc1cc(c(CC=C(C)C)c(c1O)O)c1coc2cc(cc(c2c1=O)O)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2442950
PubChem CID:   12096316
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0002901] Isoflav-2-enes
          • [CHEMONTID:0000494] Isoflavones
            • [CHEMONTID:0003580] 2'-prenylated isoflavones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO4010 Flemingia philippinensis Species Fabaceae Eukaryota Roots n.a. n.a. PMID[24054487]
NPO4010 Flemingia philippinensis Species Fabaceae Eukaryota roots n.a. n.a. PMID[24412339]
NPO4010 Flemingia philippinensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO4010 Flemingia philippinensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO4010 Flemingia philippinensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO4010 Flemingia philippinensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT344 Individual Protein Sialidase Clostridium perfringens Ki = 7860.0 nM PMID[523818]
NPT344 Individual Protein Sialidase Clostridium perfringens IC50 = 7850.0 nM PMID[523818]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC93552 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.966 High Similarity NPC85131
0.9658 High Similarity NPC203077
0.9658 High Similarity NPC238279
0.9658 High Similarity NPC166036
0.9597 High Similarity NPC107109
0.9592 High Similarity NPC38545
0.9592 High Similarity NPC171916
0.9536 High Similarity NPC37543
0.9536 High Similarity NPC199463
0.9474 High Similarity NPC85121
0.947 High Similarity NPC14561
0.947 High Similarity NPC77807
0.947 High Similarity NPC5379
0.9463 High Similarity NPC256406
0.9419 High Similarity NPC303174
0.9408 High Similarity NPC178976
0.94 High Similarity NPC324233
0.94 High Similarity NPC323626
0.9286 High Similarity NPC84571
0.9276 High Similarity NPC134287
0.9276 High Similarity NPC130589
0.9272 High Similarity NPC474993
0.9267 High Similarity NPC470568
0.9262 High Similarity NPC203747
0.9262 High Similarity NPC80710
0.9262 High Similarity NPC139364
0.9262 High Similarity NPC254702
0.9262 High Similarity NPC194653
0.9252 High Similarity NPC38065
0.9252 High Similarity NPC242893
0.9236 High Similarity NPC43319
0.9231 High Similarity NPC270837
0.9226 High Similarity NPC311740
0.9221 High Similarity NPC210459
0.9216 High Similarity NPC282307
0.9216 High Similarity NPC170026
0.9216 High Similarity NPC475799
0.9216 High Similarity NPC13779
0.9205 High Similarity NPC470569
0.9205 High Similarity NPC154345
0.92 High Similarity NPC40290
0.92 High Similarity NPC288036
0.92 High Similarity NPC97029
0.92 High Similarity NPC97028
0.92 High Similarity NPC65589
0.92 High Similarity NPC69430
0.92 High Similarity NPC264289
0.92 High Similarity NPC158338
0.92 High Similarity NPC200060
0.92 High Similarity NPC333691
0.92 High Similarity NPC195763
0.92 High Similarity NPC264550
0.92 High Similarity NPC142876
0.92 High Similarity NPC139293
0.92 High Similarity NPC100985
0.9195 High Similarity NPC190648
0.9195 High Similarity NPC126767
0.9195 High Similarity NPC34802
0.9195 High Similarity NPC118027
0.9195 High Similarity NPC312929
0.9195 High Similarity NPC56433
0.9195 High Similarity NPC245584
0.9195 High Similarity NPC289042
0.9184 High Similarity NPC471417
0.9184 High Similarity NPC84266
0.9177 High Similarity NPC218226
0.9167 High Similarity NPC470694
0.9167 High Similarity NPC294965
0.9161 High Similarity NPC36217
0.9161 High Similarity NPC119224
0.9161 High Similarity NPC321399
0.9161 High Similarity NPC474960
0.9156 High Similarity NPC273843
0.9156 High Similarity NPC52889
0.9156 High Similarity NPC78103
0.915 High Similarity NPC39184
0.915 High Similarity NPC234255
0.915 High Similarity NPC67396
0.9145 High Similarity NPC471982
0.9145 High Similarity NPC312338
0.9145 High Similarity NPC40356
0.9145 High Similarity NPC154683
0.9145 High Similarity NPC149889
0.9145 High Similarity NPC164912
0.9145 High Similarity NPC106976
0.9139 High Similarity NPC3825
0.9139 High Similarity NPC472279
0.9139 High Similarity NPC280295
0.9139 High Similarity NPC147735
0.9139 High Similarity NPC290954
0.9139 High Similarity NPC10467
0.9139 High Similarity NPC255641
0.9139 High Similarity NPC88804
0.9133 High Similarity NPC27221
0.9133 High Similarity NPC256672
0.9133 High Similarity NPC7025
0.9128 High Similarity NPC12377
0.9122 High Similarity NPC105213
0.9116 High Similarity NPC284556
0.9116 High Similarity NPC301178
0.9116 High Similarity NPC94076
0.9116 High Similarity NPC182255
0.9108 High Similarity NPC236132
0.9108 High Similarity NPC186686
0.9108 High Similarity NPC207690
0.9108 High Similarity NPC101769
0.9103 High Similarity NPC278427
0.9103 High Similarity NPC66288
0.9097 High Similarity NPC184755
0.9097 High Similarity NPC74178
0.9091 High Similarity NPC472455
0.9091 High Similarity NPC142339
0.9091 High Similarity NPC24640
0.9085 High Similarity NPC192083
0.9085 High Similarity NPC74924
0.9085 High Similarity NPC210942
0.9085 High Similarity NPC298692
0.9085 High Similarity NPC124714
0.9085 High Similarity NPC250557
0.9085 High Similarity NPC213896
0.9085 High Similarity NPC169990
0.9079 High Similarity NPC205046
0.9079 High Similarity NPC78505
0.9079 High Similarity NPC302783
0.9079 High Similarity NPC474417
0.9079 High Similarity NPC72958
0.9079 High Similarity NPC45291
0.9079 High Similarity NPC118427
0.9079 High Similarity NPC19980
0.9079 High Similarity NPC59162
0.9079 High Similarity NPC149526
0.9079 High Similarity NPC473201
0.9079 High Similarity NPC478148
0.9079 High Similarity NPC304295
0.9079 High Similarity NPC232645
0.9073 High Similarity NPC329933
0.9067 High Similarity NPC7943
0.9067 High Similarity NPC125449
0.9067 High Similarity NPC22005
0.9067 High Similarity NPC123202
0.9067 High Similarity NPC188074
0.906 High Similarity NPC157133
0.9057 High Similarity NPC474024
0.9054 High Similarity NPC476054
0.9054 High Similarity NPC287722
0.9048 High Similarity NPC259166
0.9048 High Similarity NPC204985
0.9048 High Similarity NPC172250
0.9048 High Similarity NPC213659
0.9048 High Similarity NPC215311
0.9048 High Similarity NPC48624
0.9048 High Similarity NPC144118
0.9048 High Similarity NPC80962
0.9048 High Similarity NPC326109
0.9048 High Similarity NPC219917
0.9048 High Similarity NPC253822
0.9045 High Similarity NPC329760
0.9045 High Similarity NPC201800
0.9045 High Similarity NPC211107
0.9038 High Similarity NPC14353
0.9038 High Similarity NPC228785
0.9038 High Similarity NPC297212
0.9038 High Similarity NPC328102
0.9038 High Similarity NPC476283
0.9038 High Similarity NPC28241
0.9038 High Similarity NPC56085
0.9038 High Similarity NPC471973
0.9032 High Similarity NPC236796
0.9032 High Similarity NPC291508
0.9032 High Similarity NPC472963
0.9032 High Similarity NPC136674
0.9026 High Similarity NPC80534
0.9026 High Similarity NPC113906
0.9026 High Similarity NPC472280
0.9026 High Similarity NPC200761
0.9026 High Similarity NPC45849
0.9026 High Similarity NPC321779
0.9026 High Similarity NPC133392
0.9026 High Similarity NPC168247
0.9026 High Similarity NPC152951
0.9026 High Similarity NPC56786
0.9026 High Similarity NPC117992
0.9026 High Similarity NPC470327
0.9026 High Similarity NPC230149
0.9026 High Similarity NPC477503
0.9026 High Similarity NPC57674
0.902 High Similarity NPC100971
0.902 High Similarity NPC157784
0.902 High Similarity NPC470337
0.902 High Similarity NPC51824
0.902 High Similarity NPC37684
0.902 High Similarity NPC180944
0.902 High Similarity NPC113608
0.902 High Similarity NPC131266
0.902 High Similarity NPC209487
0.902 High Similarity NPC269451
0.902 High Similarity NPC249570
0.902 High Similarity NPC181209
0.902 High Similarity NPC63187
0.902 High Similarity NPC35763

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC93552 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9085 High Similarity NPD2393 Clinical (unspecified phase)
0.8805 High Similarity NPD6232 Discontinued
0.8774 High Similarity NPD1934 Approved
0.8758 High Similarity NPD7473 Discontinued
0.8742 High Similarity NPD1511 Approved
0.8718 High Similarity NPD2801 Approved
0.8707 High Similarity NPD1510 Phase 2
0.8645 High Similarity NPD4380 Phase 2
0.8627 High Similarity NPD1512 Approved
0.8608 High Similarity NPD3882 Suspended
0.8599 High Similarity NPD7819 Suspended
0.8571 High Similarity NPD1607 Approved
0.8562 High Similarity NPD4378 Clinical (unspecified phase)
0.8509 High Similarity NPD6959 Discontinued
0.8456 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.8442 Intermediate Similarity NPD2532 Approved
0.8442 Intermediate Similarity NPD2534 Approved
0.8442 Intermediate Similarity NPD2533 Approved
0.8435 Intermediate Similarity NPD1240 Approved
0.8411 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8364 Intermediate Similarity NPD3818 Discontinued
0.8354 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8354 Intermediate Similarity NPD6166 Phase 2
0.8354 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8323 Intermediate Similarity NPD7075 Discontinued
0.8313 Intermediate Similarity NPD3817 Phase 2
0.8313 Intermediate Similarity NPD5844 Phase 1
0.8311 Intermediate Similarity NPD943 Approved
0.8289 Intermediate Similarity NPD1549 Phase 2
0.8278 Intermediate Similarity NPD2796 Approved
0.8261 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.825 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8224 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8224 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8221 Intermediate Similarity NPD5494 Approved
0.8204 Intermediate Similarity NPD7054 Approved
0.8199 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD6801 Discontinued
0.8176 Intermediate Similarity NPD6599 Discontinued
0.8155 Intermediate Similarity NPD7074 Phase 3
0.8155 Intermediate Similarity NPD7472 Approved
0.8141 Intermediate Similarity NPD7390 Discontinued
0.8125 Intermediate Similarity NPD7411 Suspended
0.8107 Intermediate Similarity NPD6797 Phase 2
0.8098 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8065 Intermediate Similarity NPD3750 Approved
0.8059 Intermediate Similarity NPD7251 Discontinued
0.8039 Intermediate Similarity NPD2935 Discontinued
0.8025 Intermediate Similarity NPD6799 Approved
0.8025 Intermediate Similarity NPD1465 Phase 2
0.7975 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7974 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7953 Intermediate Similarity NPD6559 Discontinued
0.7943 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7927 Intermediate Similarity NPD7768 Phase 2
0.7917 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD7808 Phase 3
0.7907 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7895 Intermediate Similarity NPD230 Phase 1
0.7888 Intermediate Similarity NPD3226 Approved
0.7882 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7843 Intermediate Similarity NPD6651 Approved
0.7831 Intermediate Similarity NPD6234 Discontinued
0.7831 Intermediate Similarity NPD919 Approved
0.7806 Intermediate Similarity NPD6100 Approved
0.7806 Intermediate Similarity NPD6099 Approved
0.7806 Intermediate Similarity NPD1551 Phase 2
0.7798 Intermediate Similarity NPD5710 Approved
0.7798 Intermediate Similarity NPD5711 Approved
0.7791 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD3749 Approved
0.7771 Intermediate Similarity NPD2800 Approved
0.7764 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7756 Intermediate Similarity NPD2346 Discontinued
0.7753 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7744 Intermediate Similarity NPD37 Approved
0.7742 Intermediate Similarity NPD3748 Approved
0.7738 Intermediate Similarity NPD1247 Approved
0.7722 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7722 Intermediate Similarity NPD4628 Phase 3
0.7692 Intermediate Similarity NPD5408 Approved
0.7692 Intermediate Similarity NPD5405 Approved
0.7692 Intermediate Similarity NPD5406 Approved
0.7692 Intermediate Similarity NPD5404 Approved
0.7658 Intermediate Similarity NPD1243 Approved
0.7654 Intermediate Similarity NPD5403 Approved
0.7651 Intermediate Similarity NPD5402 Approved
0.765 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD3926 Phase 2
0.7632 Intermediate Similarity NPD3027 Phase 3
0.761 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD4967 Phase 2
0.7605 Intermediate Similarity NPD4965 Approved
0.7605 Intermediate Similarity NPD4966 Approved
0.76 Intermediate Similarity NPD1470 Approved
0.76 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7568 Intermediate Similarity NPD1201 Approved
0.7561 Intermediate Similarity NPD7458 Discontinued
0.755 Intermediate Similarity NPD2798 Approved
0.7546 Intermediate Similarity NPD920 Approved
0.7531 Intermediate Similarity NPD5401 Approved
0.7529 Intermediate Similarity NPD7199 Phase 2
0.7516 Intermediate Similarity NPD4625 Phase 3
0.7516 Intermediate Similarity NPD2799 Discontinued
0.7516 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7514 Intermediate Similarity NPD7228 Approved
0.7513 Intermediate Similarity NPD8151 Discontinued
0.75 Intermediate Similarity NPD9494 Approved
0.75 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7003 Approved
0.7486 Intermediate Similarity NPD5953 Discontinued
0.7484 Intermediate Similarity NPD1613 Approved
0.7484 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7472 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7467 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7459 Intermediate Similarity NPD6782 Approved
0.7459 Intermediate Similarity NPD6777 Approved
0.7459 Intermediate Similarity NPD6779 Approved
0.7459 Intermediate Similarity NPD6776 Approved
0.7459 Intermediate Similarity NPD6778 Approved
0.7459 Intermediate Similarity NPD6781 Approved
0.7459 Intermediate Similarity NPD6780 Approved
0.7458 Intermediate Similarity NPD8312 Approved
0.7458 Intermediate Similarity NPD8313 Approved
0.7455 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7451 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7442 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.743 Intermediate Similarity NPD8150 Discontinued
0.7423 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7421 Intermediate Similarity NPD2344 Approved
0.74 Intermediate Similarity NPD3972 Approved
0.7371 Intermediate Similarity NPD7286 Phase 2
0.7365 Intermediate Similarity NPD1651 Approved
0.7362 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD2313 Discontinued
0.7355 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.734 Intermediate Similarity NPD7435 Discontinued
0.7314 Intermediate Similarity NPD3751 Discontinued
0.7303 Intermediate Similarity NPD1283 Approved
0.7285 Intermediate Similarity NPD9269 Phase 2
0.7284 Intermediate Similarity NPD8166 Discontinued
0.7249 Intermediate Similarity NPD7698 Approved
0.7249 Intermediate Similarity NPD7696 Phase 3
0.7249 Intermediate Similarity NPD7697 Approved
0.7239 Intermediate Similarity NPD2309 Approved
0.7239 Intermediate Similarity NPD6190 Approved
0.7226 Intermediate Similarity NPD4908 Phase 1
0.7222 Intermediate Similarity NPD2654 Approved
0.7216 Intermediate Similarity NPD7177 Discontinued
0.7215 Intermediate Similarity NPD447 Suspended
0.7212 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7211 Intermediate Similarity NPD7870 Phase 2
0.7211 Intermediate Similarity NPD7871 Phase 2
0.7208 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7204 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.72 Intermediate Similarity NPD4626 Approved
0.7196 Intermediate Similarity NPD6823 Phase 2
0.7189 Intermediate Similarity NPD6534 Approved
0.7189 Intermediate Similarity NPD4363 Phase 3
0.7189 Intermediate Similarity NPD6535 Approved
0.7189 Intermediate Similarity NPD4360 Phase 2
0.7188 Intermediate Similarity NPD4308 Phase 3
0.7188 Intermediate Similarity NPD7701 Phase 2
0.7184 Intermediate Similarity NPD3787 Discontinued
0.7184 Intermediate Similarity NPD7229 Phase 3
0.7152 Intermediate Similarity NPD4060 Phase 1
0.7151 Intermediate Similarity NPD7685 Pre-registration
0.7151 Intermediate Similarity NPD4361 Phase 2
0.7151 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD1203 Approved
0.7143 Intermediate Similarity NPD5242 Approved
0.7143 Intermediate Similarity NPD8434 Phase 2
0.7135 Intermediate Similarity NPD4288 Approved
0.7134 Intermediate Similarity NPD3268 Approved
0.7134 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD3764 Approved
0.7127 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD4749 Approved
0.7117 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD6832 Phase 2
0.7113 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD7874 Approved
0.7107 Intermediate Similarity NPD1933 Approved
0.7105 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD1281 Approved
0.7105 Intermediate Similarity NPD1610 Phase 2
0.7099 Intermediate Similarity NPD1471 Phase 3
0.7091 Intermediate Similarity NPD3300 Phase 2
0.7083 Intermediate Similarity NPD1653 Approved
0.7081 Intermediate Similarity NPD7033 Discontinued
0.7078 Intermediate Similarity NPD1876 Approved
0.7077 Intermediate Similarity NPD7801 Approved
0.7074 Intermediate Similarity NPD7699 Phase 2
0.7074 Intermediate Similarity NPD7700 Phase 2
0.7067 Intermediate Similarity NPD1548 Phase 1
0.7066 Intermediate Similarity NPD6273 Approved
0.7056 Intermediate Similarity NPD7240 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data